Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03WOG
|
|||
| Drug Name |
Evinacumab
|
|||
| Synonyms |
REGN1500; ANGPTL-1 antibody
Click to Show/Hide
|
|||
| Indication | Hypercholesterolaemia [ICD-11: 5C80.0; ICD-9: 272] | Approved | [1] | |
| Elevated C-reactive protein [ICD-11: MA14.15] | Phase 2 | [2] | ||
| Familial hypercholesterolemia [ICD-11: 5C80.00; ICD-10: E78.0] | Phase 2 | [3] | ||
| Company |
Regeneron Pharmaceuticals Tarrytown, NY
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Angiopoietin-related protein 3 (ANGPTL3) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2021 | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.